ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,407.56
0.82%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Noticias

LQDA Liquidia Corporation

12.79
-0.19 (-1.46%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Liquidia Corporation LQDA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.19 -1.46% 12.79 23:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
13.15 12.66 13.23 12.79 12.98
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/4/202408:00GLOBELiquidia Corporation to Present at 23rd Annual Needham..
01/4/202405:00GLOBEUpdate on Favorable Legal and Regulatory Outcomes Clearing..
13/3/202405:00GLOBELiquidia Corporation Reports Full Year 2023 Financial..
06/3/202405:30GLOBELiquidia Corporation to Report Full Year 2023 Financial..
04/3/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202405:30GLOBELiquidia Corporation Announces Poster Presentation at the..
25/1/202406:01EDGAR2Form 8-K - Current report
25/1/202405:00GLOBELiquidia Corporation Provides Update on New Drug Application..
23/1/202406:30EDGAR2Form 8-K - Current report
19/1/202406:01EDGAR2Form 8-K - Current report
19/1/202405:30GLOBELiquidia Corporation Announces Updates to Operations..
16/1/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202406:42EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202415:15EDGAR2Form 8-K - Current report
08/1/202407:22GLOBELiquidia Corporation Files Response to United Therapeutics..
05/1/202405:45GLOBELiquidia Provides Update on Clinical Pipeline Targeting PAH..
04/1/202420:37EDGAR2Form 8-K - Current report
04/1/202408:10GLOBELiquidia Corporation Announces $100 Million in New..
03/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202405:45GLOBELiquidia Corporation to Present at 42nd Annual J.P. Morgan..
28/12/202315:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/12/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202316:16EDGAR2Form 8-K - Current report
20/12/202315:56GLOBEU.S. Federal Circuit Affirms Earlier PTAB Decision to..
18/12/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:02EDGAR2Form 8-K - Current report
12/12/202315:41EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/12/202307:44EDGAR2Form 8-K - Current report
12/12/202306:13GLOBELiquidia Announces Pricing of Public Offering of Common..
12/12/202306:04EDGAR2Form 8-K - Current report
05/12/202320:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202307:30EDGAR2Form 8-K - Current report
07/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202305:36EDGAR2Form 8-K - Current report
07/11/202305:30GLOBELiquidia Corporation Reports Third Quarter 2023 Financial..
31/10/202305:30GLOBELiquidia Corporation to Report Third Quarter 2023 Financial..
02/10/202306:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
25/9/202316:00EDGAR2Form 8-K - Current report
25/9/202315:09GLOBEFDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
06/9/202315:37EDGAR2Form 8-K - Current report
06/9/202315:30GLOBEUnited Therapeutics Corporation Files Lawsuit Alleging..
05/9/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202305:00EDGAR2Form 8-K - Current report
10/8/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202305:00GLOBELiquidia Corporation Reports Second Quarter 2023 Financial..
10/8/202305:00EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
LQDA
Liquidia
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados